KT

Kent B. Thudium

EL E.R. Squibb & Sons, L.L.C.: 5 patents #1 of 11Top 10%
BS Bristol-Myers Squibb: 1 patents #152 of 557Top 30%
📍 Oakland, CA: #29 of 883 inventorsTop 4%
🗺 California: #2,806 of 65,961 inventorsTop 5%
Overall (2022): #21,669 of 548,613Top 4%
6
Patents 2022

Issued Patents 2022

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11530267 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Mark J. Selby, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc 2022-12-20
11512130 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Mark J. Selby, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc 2022-11-29
11466092 Antibodies against OX-40 and uses thereof Zhehong CAI, Indrani Chakraborty, Marie-Michelle Navarro GARCIA, Thomas D. Kempe, Alan J. Korman +12 more 2022-10-11
11236163 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Mark J. Selby, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc 2022-02-01
11236164 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Mark J. Selby, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc 2022-02-01
11236165 Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof Mark J. Selby, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc 2022-02-01